Under‐ and overdosing insulin in the hospital: A retrospective cohort study of dose deviation and patient outcomes
Diabetic Medicine · 2026
DOI: 10.1111/dme.70403 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetic Medicine, 2026. Verfasst von Hussein Zaitoon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gray School of Medicine, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Insulin, Diabetes Mellitus, Type 2, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
Glycaemic abnormalities during hospitalization are common and linked to morbidity and mortality, yet little is known about how deviations from guideline‐recommended insulin dosing affect outcomes. The aim of this study is to examine whether deviation from an expected insulin dose in non‐critically ill hospitalized adults with type 2 diabetes, compared with guideline‐concordant dosing, is associated with mortality, length of stay or dysglycaemias.
Methods
This retrospective cohort study included adults with type 2 diabetes hospitalized at a tertiary academic medical centre (2010–2025) who received ≥ 24 h of subcutaneous insulin. The expected total daily insulin dose (TDID) was calculated based on guideline‐concordant dosing using the ADA‐recommended range (0.3–0.6 units/kg/day), and the observed TDID was derived from medication records. Patients were classified as undertreated (< 0.3 units/kg/day), guideline‐concordant (0.3–0.6 units/kg/day) or overtreated (> 0.6 units/kg/day). Outcomes included length of stay, and 30‐day mortality, hypoglycaemia and hyperglycaemia.
Results
Among 3430 hospitalized adults with type 2 diabetes receiving subcutaneous insulin, 37.6% received guideline‐concordant dosing, 43.7% were undertreated, and 18.7% were overtreated. Undertreatment was independently associated with increased 30‐day mortality (aHR 1.273, 95% CI 1.024–1.583; p = 0.03), while overtreatment was not. Undertreated patients had more hyperglycaemia and longer hospital stays ( p < 0.001), whereas hypoglycaemia rates were similar between groups.
Conclusion
Deviation from guideline‐based insulin dosing is common in hospitalized adults with type 2 diabetes. Undertreatment was associated with increased 30‐day mortality and prolonged hospitalization. Monitoring insulin dose deviation may help identify patients at risk for adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gray School of Medicine, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- The Institute of Pediatric Endocrinology, Diabetes and Metabolism, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Division of Diabetes, UT Health San Antonio, San Antonio, Texas, USA.
- The Institute of Endocrinology and Metabolism, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Internal Medicine Department D, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Department of Biomedical Sciences for Health, Università Degli Studi di Milano, Milan, Italy.
ORCID-Profile: Hussein Zaitoon, Eugene Feigin
Zitieren
APA
Zaitoon, H., Matsri, S., Nagler, S., Lalovich, M. M., DeFronzo, R. A., & Feigin, E. (2026). Under‐ and overdosing insulin in the hospital: A retrospective cohort study of dose deviation and patient outcomes. Diabetic Medicine. https://doi.org/10.1111/dme.70403
Vancouver
Zaitoon H, Matsri S, Nagler S, Lalovich MM, DeFronzo RA, Feigin E. Under‐ and overdosing insulin in the hospital: A retrospective cohort study of dose deviation and patient outcomes. Diabetic Medicine. 2026. doi:10.1111/dme.70403
BibTeX
@article{Zaitoon2026,
author = {Zaitoon, Hussein and Matsri, Sher and Nagler, Shira and Lalovich, Matteo M and DeFronzo, Ralph A and Feigin, Eugene},
title = {Under‐ and overdosing insulin in the hospital: A retrospective cohort study of dose deviation and patient outcomes},
journal = {Diabetic Medicine},
year = {2026},
doi = {10.1111/dme.70403}
}
EUVIMED